Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
News|Articles|March 27, 2018
Natoli Engineering Enters Encapsulation Machine Replacement Parts Market
Author(s)Pharmaceutical Technology Editors
Natoli acquired Carlisle Precision Machining, which supplies replacement parts for encapsulation equipment.
Advertisement
Tablet-press and tooling manufacturer Natoli Engineering Company, headquartered in Missouri, acquired Carlisle Precision Machining (CPM) of Nampa, Idaho, Natoli announced on March 27, 2018. CPM supplies aftermarket change and spare parts for many brands of Bosch-type encapsulation machines used in the pharmaceutical and nutraceutical industries. As a subsidiary of Natoli Engineering Company, the organization has been renamed Carlisle Precision Encapsulation Parts. Natoli Engineering Company has several other divisions, including Natoli Replacement Parts, Turrets, & Accessories, which manufactures tablet-press replacement parts.
Encapsulation spare parts from Carlisle include dosing disks, segments, alignment pins, sorting blocks, and magazine assemblies. In addition to an expanded refurbishment service for many brands of encapsulation machines, Carlisle makes custom encapsulation machine parts that can be engineered to a customer’s exact specifications. Carlisle Precision Encapsulation Parts also offers training and consulting services.
Source:
Advertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Winners of the 2026 CPHI Pharma Awards Announced
2
Thermo Fisher Scientific Exhibits New Solutions and Expanded Capabilities at CPHI Milan
3
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
4
Can Continuous Tableting End Scale-Up for Complex Oral Drugs?
5